The sentiment shift gained momentum following statements from Anthropic CEO Dario Amodei, who urged for stricter oversight to mitigate potential misuse of emerging technologies. This caution hit semiconductor manufacturers particularly hard, with France’s Soitec and Germany’s Infineon leading the downward trend as investors reassessed the risks associated with rapid AI integration.
While technology struggled, the broader market faced pressure from multiple fronts. Geopolitical instability pushed oil prices higher, reviving inflationary concerns and forcing market participants to recalibrate their expectations for interest rate hikes from the U.S. Federal Reserve. Amid this volatility, healthcare provided a rare defensive buffer; GSK shares climbed following positive clinical trial results for its new lung cancer treatment, offering a stark contrast to the tech-led selloff.





Comments (0)
No comments yet. Be the first!